Literature DB >> 17166125

Is the second phase of the formalin test useful to predict activity in chronic constriction injury models? A pharmacological comparison in different species.

K Vissers1, V Hoffmann, F Geenen, R Biermans, T Meert.   

Abstract

This study presents data of several reference drugs in rats and gerbils for both the second phase of the formalin test and the cold allodynia in animals with a constriction injury of the sciatic nerve. A pharmacological validation of the formalin test and the CCI model in gerbils was performed. It was evaluated whether the second phase of the formalin test could be used as a pharmacological screening to predict outcome in the cold plate test in CCI animals. Male Sprague Dawley and Wistar rats and male gerbils were used for both tests. For the formalin test, animals were injected in the right hind paw (5% formalin rat: 0.05 microl; gerbil: 0.01 microl) and flinching and licking or biting were recorded. For CCI testing, a Bennett operation was performed on the left hind paw 7 days before testing. Cold plate allodynia was evaluated before and after drug treatment. In rats, a good correlation between both test conditions for morphine, fentanyl, MK-801 and flunarizine was found. Clonidine tends to have more activity in the second phase of the formalin test, whereas baclofen, tramadol, amitryptiline, ketamine and topiramate demonstrate to be more active in the cold plate. In gerbils, a good correlation between both test conditions for fentanyl and ketoprofen was found. Tramadol and CP-96345 tend to have more activity in the second phase of the formalin test, whereas morphine, SR-48968, SR-142801 and R116301 demonstrates to be more active in the cold plate test. In the present acute test conditions, there is a correlation in the pharmacological activity in rats and gerbils for the tested compounds a correlation between the second phase of the formalin test and the cold allodynia in CCI animals is found. Comparing to human data the screening drugs tested in this study show a correlation between animal and human studies in these specific circumstances. Further validation studies are needed to make these correlations clinical applicable.

Entities:  

Year:  2003        PMID: 17166125     DOI: 10.1111/j.1530-7085.2003.03033.x

Source DB:  PubMed          Journal:  Pain Pract        ISSN: 1530-7085            Impact factor:   3.183


  9 in total

1.  The role of alpha5 nicotinic acetylcholine receptors in mouse models of chronic inflammatory and neuropathic pain.

Authors:  Deniz Bagdas; Shakir D AlSharari; Kelen Freitas; Matthew Tracy; M Imad Damaj
Journal:  Biochem Pharmacol       Date:  2015-04-28       Impact factor: 5.858

2.  Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs.

Authors:  F S Hasnie; J Breuer; S Parker; V Wallace; J Blackbeard; I Lever; P R Kinchington; A H Dickenson; T Pheby; A S C Rice
Journal:  Neuroscience       Date:  2006-12-29       Impact factor: 3.590

3.  Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice.

Authors:  Cruz M Cendán; José M Pujalte; Enrique Portillo-Salido; José M Baeyens
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

4.  Antinociceptive effect of an ethanolic extract of the aerial parts of Hilleria latifolia (Lam.) H. Walt. (Phytolaccaceae).

Authors:  Eric Woode; Wonder K M Abotsi
Journal:  J Pharm Bioallied Sci       Date:  2011-07

5.  Assessment of 5-HT(7) Receptor Agonists Selectivity Using Nociceptive and Thermoregulation Tests in Knockout versus Wild-Type Mice.

Authors:  Alex Brenchat; Maria Rocasalbas; Daniel Zamanillo; Michel Hamon; José Miguel Vela; Luz Romero
Journal:  Adv Pharmacol Sci       Date:  2012-06-19

6.  Inhibition of spinal 15-LOX-1 attenuates TLR4-dependent, nonsteroidal anti-inflammatory drug-unresponsive hyperalgesia in male rats.

Authors:  Ann M Gregus; Matthew W Buczynski; Darren S Dumlao; Paul C Norris; Ganesha Rai; Anton Simeonov; David J Maloney; Ajit Jadhav; Qinghao Xu; Spencer C Wei; Bethany L Fitzsimmons; Edward A Dennis; Tony L Yaksh
Journal:  Pain       Date:  2018-12       Impact factor: 7.926

7.  The Ehrlich tumor induces pain-like behavior in mice: a novel model of cancer pain for pathophysiological studies and pharmacological screening.

Authors:  Cassia Calixto-Campos; Ana C Zarpelon; Mab Corrêa; Renato D R Cardoso; Felipe A Pinho-Ribeiro; Rubens Cecchini; Estefania G Moreira; Jefferson Crespigio; Catia C F Bernardy; Rubia Casagrande; Waldiceu A Verri
Journal:  Biomed Res Int       Date:  2013-08-29       Impact factor: 3.411

8.  Chemical Composition and Role of Opioidergic System in Antinociceptive Effect of Ziziphora Clinopodioides Essential Oil.

Authors:  Faezeh Mohammadifard; Samad Alimohammadi
Journal:  Basic Clin Neurosci       Date:  2018-09-01

9.  Antinociceptive Effects of Prim-O-Glucosylcimifugin in Inflammatory Nociception via Reducing Spinal COX-2.

Authors:  Liu-Qing Wu; Yu Li; Yuan-Yan Li; Shi-Hao Xu; Zong-Yong Yang; Zheng Lin; Jun Li
Journal:  Biomol Ther (Seoul)       Date:  2016-05-31       Impact factor: 4.634

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.